Form 4: PACCAR EVP Dozier Exercises Options, Sells Shares
Insider Transaction Report
PACCAR Executive Vice President C. Michael Dozier reported exercising stock options and subsequently selling a significant portion of common stock.
Summary
- C. Michael Dozier, Executive Vice President of PACCAR INC, reported transactions on February 3, 2026, under a Rule 10b5-1 plan.
- Exercised 38,900 stock options at an exercise price of $71.95 per share, acquiring common stock.
- Exercised 20,682 stock options at an exercise price of $61.26 per share, acquiring common stock.
- Exercised 19,494 stock options at an exercise price of $62.8667 per share, acquiring common stock.
- Sold a total of 79,076 shares of common stock at a weighted average sale price of $127.9189 per share, with individual sale prices ranging from $127.6500 to $128.3400.
- Following these transactions, Dozier directly owns 34,656 shares of common stock.
- Indirectly owns 20,172.896 shares of common stock through the PACCAR Savings Investment Plan (SIP).
- Retains 28,610 stock options with an exercise price of $104.16, exercisable from January 1, 2027, and expiring February 5, 2034.
- Retains 25,460 stock options with an exercise price of $109.13, exercisable from January 1, 2028, and expiring February 3, 2035.
- Holds 5,754 restricted stock units (LTIP) convertible to common stock on a one-for-one basis upon vesting.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, typical for executive compensation and portfolio management, with no direct positive or negative implications for company operations or future performance.
Positives
- The executive realized a significant profit by selling shares at a weighted average price of $127.9189, substantially higher than the option exercise prices ($71.95, $61.26, $62.8667).
Negatives
- An executive selling a large number of shares, even if pre-planned, can sometimes be perceived negatively by the market, though it is a common practice for liquidity and portfolio diversification.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
StockSavvy.ai notes that insider sales, particularly those following option exercises and conducted under a Rule 10b5-1 plan, are common occurrences for executives managing their personal portfolios. These transactions are typically routine disclosures related to executive compensation and do not inherently signal a change in company fundamentals or strategic direction within the broader industry.
Stakeholder Impact
- Shareholders: May observe the executive's portfolio management activities, but the routine nature of these transactions, especially under a 10b5-1 plan, is unlikely to significantly impact shareholder sentiment or company strategy.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 01/01/2024 | Date exercisable for 20,682 stock options. |
| 01/01/2025 | Date exercisable for 19,494 stock options. |
| 01/01/2026 | Date exercisable for 38,900 stock options. |
| 02/03/2026 | Transaction Date for option exercises and common stock sale. |
| 01/01/2027 | Date exercisable for 28,610 stock options. |
| 01/01/2028 | Date exercisable for 25,460 stock options. |
| 02/02/2031 | Expiration Date for 20,682 stock options. |
| 02/07/2032 | Expiration Date for 19,494 stock options. |
| 02/08/2033 | Expiration Date for 38,900 stock options. |
| 02/05/2034 | Expiration Date for 28,610 stock options. |
| 02/03/2035 | Expiration Date for 25,460 stock options. |
Recommendation
holdThis Form 4 filing details routine insider transactions involving option exercises and subsequent stock sales by an executive. While the sale of shares might be perceived negatively, it is a common practice for executives to monetize vested options, often as part of pre-arranged trading plans (Rule 10b5-1). The filing does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing itself does not present a compelling reason to buy or sell based solely on this information.
Keywords
PACCAR, PCAR, Form 4, Insider Trading, Stock Options, Executive Compensation, C. Michael Dozier, Stock Sale, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.